Navigation Links
Evotec Reports Positive Proof-of-Concept Top-Line Results with,Insomnia Drug Candidate EVT 201

ected to be announced by Q4 2007 / Q1 2008.

Study design

This US, multi-centre, double-blind trial was designed to evaluate the efficacy of EVT 201 in a three way cross-over design in 67 patients with primary insomnia. Patients were screened for entry into the study and the eligibility criteria included: a diagnosis of primary insomnia according to DSM (Diagnostic and Statistical Manual of Mental Disorders) IV; mean LPS > 20 minutes, mean WASO �³ 40 minutes, mean TST 240-420 minutes, all determined during two consecutive nights PSG evaluation. Patients received two dose levels of EVT 201 and placebo, in a random order, for two consecutive nights with a 5-12 day washout between each period.

The primary endpoints of this trial were to assess Wake After Sleep Onset (WASO) as well as Total Sleep Time (TST) determined by polysomnography (PSG). The secondary endpoints included additional PSG-based measures such as latency to persistent sleep, number of awakenings and effects on sleep architecture. In addition, patients evaluated sleep quality and quantity. Residual sedation was assessed by the Digit Symbol Substitution Test (DSST) and a categorical patient rating. Safety measures included adverse events and laboratory data.

Conference call

Evotec will hold a conference call today at 4.00 pm CET (3.00 pm GMT/10.00 am US time East Coast) to discuss the top-line results.

    Conference call numbers (listen only):


    Europe: +49-(0)69-5007-1309 (Germany)

            +44-(0)20-7806-1955 (UK)


    US: +1-718-354-1388



    Webcast: www.evotec.com

    The presentation slides are available via the webcast.

A replay of the conference call will be available for 24 hours and can be accessed in Europe by dialing +49-(0)69-22222-0418 (Germany) or +44-(0)20-7806-1970 (UK) and in the US by +1-718-354-1112. The access code is 1624428#. The on-demand vers
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Evotec AG (DE) - Evotec Reports Positive Proof-of-Concept Top-Line Results with ...
2. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
3. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
4. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
5. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
6. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
7. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
8. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
9. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
10. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
11. CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS
Post Your Comments:
(Date:3/3/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/x5lz9r/global_poc ) has ... Market 2015-2019" report to their offering. , ... market to grow at a CAGR of 8.47 percent ... are IVD devices and tools used for diagnosing diseases ... of these devices helps in the rapid diagnosis of ...
(Date:3/3/2015)... 3, 2015 Konica Minolta Medical Imaging and ... today a new, integrated portable X-ray solution, the MobileArt ... available with a larger integrated console, and a 17" ... a larger viewing area to simplify operation and enhance ... for accessories and storage, along with a detector slot ...
(Date:3/3/2015)... 3, 2015  Columbia Laboratories, Inc. (Nasdaq: ... Company"), a specialty pharmaceutical company focused on pharmaceuticals for ... the 27th Annual ROTH Conference, which will take place ... Dana Point, California . Management,s presentation ... a.m. Pacific Time (12:00 p.m. Eastern Time) in the ...
Breaking Medicine Technology:Global POC Diagnostics Market 2015-2019 with Abbott Labs, Alere, Bayer Healthcare, Danaher, F. Hoffmann-La Roche & Johnson & Johnson Dominating 2Konica Minolta Medical Imaging and Shimadzu Medical Systems USA Introduce MobileArt Evolution EFX AeroDR-i with 17" Touch Monitor to Simplify Operation 2Konica Minolta Medical Imaging and Shimadzu Medical Systems USA Introduce MobileArt Evolution EFX AeroDR-i with 17" Touch Monitor to Simplify Operation 3
... June 15, 2007 /PRNewswire/ -- Results of ... trial, the first multinational Phase III study ... Actemra (either 4mg/kg,or 8mg/kg) plus methotrexate achieved ... signs and symptoms of moderate to,severe rheumatoid ...
... the European League Against Rheumatism,(EULAR) Congress Demonstrates ... Rheumatoid Arthritis, LONDON, England; PHILADELPHIA, Pennsylvania and ... and Genmab A/S (CSE: GEN) announced today ... to be presented at EULAR,2007, the Annual ...
Cached Medicine Technology:Actemra (tocilizumab) Significantly Improves Symptoms of Rheumatoid,Arthritis Compared to a Current Standard of Care 2Actemra (tocilizumab) Significantly Improves Symptoms of Rheumatoid,Arthritis Compared to a Current Standard of Care 3Actemra (tocilizumab) Significantly Improves Symptoms of Rheumatoid,Arthritis Compared to a Current Standard of Care 4Actemra (tocilizumab) Significantly Improves Symptoms of Rheumatoid,Arthritis Compared to a Current Standard of Care 5GlaxoSmithKline and Genmab Present Positive Phase II Results With,ofatumumab in Patients With Rheumatoid Arthritis (RA) 2GlaxoSmithKline and Genmab Present Positive Phase II Results With,ofatumumab in Patients With Rheumatoid Arthritis (RA) 3GlaxoSmithKline and Genmab Present Positive Phase II Results With,ofatumumab in Patients With Rheumatoid Arthritis (RA) 4GlaxoSmithKline and Genmab Present Positive Phase II Results With,ofatumumab in Patients With Rheumatoid Arthritis (RA) 5
(Date:3/3/2015)... In March, 1% for the Planet , one ... new campaign, “Know Your Source,” which calls for consumers to ... their quest for ingredient awareness and better business practices. 1% ... and partners, including King Arthur Flour, Good Culture, Farm Aid, ... for food as an environmental issue, with a focus on ...
(Date:3/3/2015)... US Air Purifiers LLC , an ... is pleased to announce that all Rabbit brand air purifiers ... to the west coast port strikes. This news comes just ... , The port strikes, which have caused ... quarter economic growth by as much as 1%, have hindered ...
(Date:3/3/2015)... Topical BioMedics, Inc., announces its March Pain Management Workshop will ... 10th, 12pm – 1pm and 4pm to 5pm. Afterward, ... , The Pain Management Workshops are free and open ... is “Opioid Addiction: An Over-Medicated Society.” It’s a ... the world’s population, yet consumers 99% of the world’s Vicodin ...
(Date:3/3/2015)... March 03, 2015 The combinatorial, ... predict antidepressant treatment outcomes for patients with depression, ... any of the individual genes that comprise the ... from the Mayo Clinic and Assurex Health, and ... , The proprietary technology of the GeneSight Psychotropic ...
(Date:3/3/2015)... — (PRWEB) March 03, 2015 -- vRad ... and radiology practice, today announced that Arlene Sussman, MD, ... will host a live webinar to explore how telemedicine ... specialized breast imaging services for women virtually anywhere. Click ... Breast Imaging Service Line” on March 4, 2015 at ...
Breaking Medicine News(10 mins):Health News:1% For the Planet Asks Consumers to “Know Your Source” 2Health News:Rabbit Air Purifiers Back In Stock at US Air Purifiers LLC 2Health News:Rabbit Air Purifiers Back In Stock at US Air Purifiers LLC 3Health News:Topical BioMedics Hosts March Pain Management Webinar 2Health News:Topical BioMedics Hosts March Pain Management Webinar 3Health News:Topical BioMedics Hosts March Pain Management Webinar 4Health News:Topical BioMedics Hosts March Pain Management Webinar 5Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 2Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 3Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 4Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 5Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 6Health News:Latest vRad Webinar: Building World-Class Breast Imaging Services Virtually Anywhere with Telemedicine Best Practices 2Health News:Latest vRad Webinar: Building World-Class Breast Imaging Services Virtually Anywhere with Telemedicine Best Practices 3Health News:Latest vRad Webinar: Building World-Class Breast Imaging Services Virtually Anywhere with Telemedicine Best Practices 4
... -- Children who live in stress-filled homes experience more ... environments, a new study finds. Researchers looked at ... 1,400 children, aged 10 to 12, in California. There ... and lung function levels in the children. ...
... Center have found four new genetic variants in the ... of systemic lupus erythemathosus ("lupus") in African American women. ... Genetics , is believed to be the first to ... MHC region and risk of lupus in African American ...
... HealthDay Reporter , THURSDAY, June 23 (HealthDay News) -- The ... dressing appeal to many, but new evidence indicates that some ... and that those who can,t may end up eating more ... at the 2011 Institute of Food Technologists annual meeting this ...
... advertising and lowered the sale price of menthol cigarettes ... of African-American students, according to a new study from ... have denied using race or ethnicity to target customers, ... shows a "predatory" marketing pattern geared to luring young ...
... (Boston MA) A group of 26 of the nation,s ... called for sweeping changes in the design, supervision and financing ... serious, preventable medical errors, and end dangerously long work ... recommendations published in the June 24 issue of the online ...
... team led by Johns Hopkins researchers has found that a ... with abnormally dense blood vessel growth in the skin lining ... of Familial Cancer , could lead to a quick ... DNA tests and colonoscopies, and sometimes goes unnoticed until cancer ...
Cached Medicine News:Health News:Stress May Worsen Lung Function in Kids Breathing Dirty Air 2Health News:New genetic risk factors of lupus found in study of African-American women 2Health News:Poor 'Fat-Tasters' May Tend to Be Heavier 2Health News:Poor 'Fat-Tasters' May Tend to Be Heavier 3Health News:Menthol cigarettes marketed in 'predatory' pattern, Stanford study shows 2Health News:Menthol cigarettes marketed in 'predatory' pattern, Stanford study shows 3Health News:Experts seek reforms to prevent errors from medical resident fatigue, lack of supervision 2Health News:Experts seek reforms to prevent errors from medical resident fatigue, lack of supervision 3Health News:Experts seek reforms to prevent errors from medical resident fatigue, lack of supervision 4Health News:Hereditary colon cancer syndrome marked by abnormally dense blood vessel growth in mouth 2Health News:Hereditary colon cancer syndrome marked by abnormally dense blood vessel growth in mouth 3
... Oximeter with SAC (Serial Autocorrelation) Technology uses ... extract SpO 2 , pulse strength, and ... This cost-effective compact monitor incorporates clinical, ... features, and a data log or trend ...
... Portable pulse oximetry monitoring system compatible ... printers. Extremely rugged and cost-effective.The ... and reliably delivers pulse oximetry wherever ... offices, outpatient clinics and hospitals. In ...
... a Pulse Oximeter and Sensor in one unit ... and pulse strength measurements on patients from pediatric ... LED display, one button keypad and auto power ... makes it ideal for emergency, hospital or clinical ...
... you want: ,Four probe choices, single degree control ... probe in the industry, gives you the power ... to. From full sulcus-to-sulcus measurements to detailed ... the clarity of images and resolution you demand., ...
Medicine Products: